Pralatrexate for Refractory or Recurrent Subcutaneous Panniculitis-Like T-Cell Lymphoma With Hemophagocytic Syndrome

Journal of the American Academy of Dermatology - United States
doi 10.1016/j.jaad.2019.07.021
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Elsevier BV

Related search

Subcutaneous Panniculitis-Like T-Cell Lymphoma

2020English

Subcutaneous Panniculitis-Like T-Cell Lymphoma

2014English

Cytophagic Histiocytic Panniculitis and Subcutaneous Panniculitis-Like T-Cell Lymphoma

Archives of Dermatology
2000English

Panniculitis-Like T-Cell-Lymphoma in the Mesentery Associated With Hemophagocytic Syndrome: Autopsy Case Report

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2019English

A Case of Subcutaneous Panniculitis-Like T-Cell Lymphoma

Skin Cancer
2003English

Case Report of Subcutaneous Panniculitis-Like T-Cell Lymphoma Complicated by Eyelid Swelling

BMC Ophthalmology
MedicineOphthalmology
2016English

Pralatrexate in Patients With Recurrent or Refractory Peripheral T-Cell Lymphomas: A Multicenter Retrospective Analysis

Scientific Reports
Multidisciplinary
2019English

Subcutaneous Panniculitis-Like T-Cell Lymphoma in a Patient With History of B-Cell Lymphoma Treated Successfully With Chemotherapy 15 Years Prior

Journal of Oncology Pharmacy Practice
MedicineOncologyPharmacology
2013English

Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy